Mirjam Stahl

3.4k total citations · 1 hit paper
94 papers, 2.0k citations indexed

About

Mirjam Stahl is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Emergency Medical Services. According to data from OpenAlex, Mirjam Stahl has authored 94 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Pulmonary and Respiratory Medicine, 21 papers in Epidemiology and 12 papers in Emergency Medical Services. Recurrent topics in Mirjam Stahl's work include Cystic Fibrosis Research Advances (71 papers), Neonatal Respiratory Health Research (45 papers) and Tracheal and airway disorders (20 papers). Mirjam Stahl is often cited by papers focused on Cystic Fibrosis Research Advances (71 papers), Neonatal Respiratory Health Research (45 papers) and Tracheal and airway disorders (20 papers). Mirjam Stahl collaborates with scholars based in Germany, United States and Switzerland. Mirjam Stahl's co-authors include Marcus Mall, Olaf Sommerburg, Mark O. Wielpütz, Simon Y. Graeber, Hans‐Ulrich Kauczor, Monika Eichinger, Michael Puderbach, Cornelia Joachim, Sébastien Boutin and Alexander H. Dalpke and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Mirjam Stahl

87 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Longitudinal effects of elexacaftor/tezacaftor/ivacaftor on sputum viscoelastic properties, airway infection and inflammation in patients with cystic fibrosis

2023 94 citations Laura Schaupp, Annalisa Addante et al. European Respiratory Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mirjam Stahl Germany	25	1.6k	282	266	239	168	94	2.0k
Carmen Casaulta Switzerland	27	1.5k 0.9×	367 1.3×	96 0.4×	201 0.8×	374 2.2×	103	2.1k
Simon Y. Graeber Germany	22	1.2k 0.7×	156 0.6×	79 0.3×	269 1.1×	119 0.7×	49	1.5k
Philippe Reix France	22	1.2k 0.7×	191 0.7×	53 0.2×	188 0.8×	243 1.4×	124	1.7k
Joanne Quan United States	13	1.9k 1.2×	552 2.0×	37 0.1×	255 1.1×	241 1.4×	18	2.6k
Kyung Min Shin South Korea	23	717 0.4×	237 0.8×	78 0.3×	180 0.8×	89 0.5×	119	1.8k
J. Masterson Ireland	14	601 0.4×	122 0.4×	69 0.3×	73 0.3×	174 1.0×	32	1.1k
Michael A. Jantz United States	25	2.5k 1.6×	234 0.8×	49 0.2×	153 0.6×	131 0.8×	71	3.1k
Jochen G. Mainz Germany	23	2.4k 1.5×	278 1.0×	23 0.1×	626 2.6×	299 1.8×	107	3.1k
Kazuro Sugi Japan	25	1.4k 0.9×	176 0.6×	110 0.4×	242 1.0×	71 0.4×	88	2.1k
Mitsuru Munakata Japan	25	1.3k 0.8×	206 0.7×	18 0.1×	261 1.1×	726 4.3×	116	2.2k

Countries citing papers authored by Mirjam Stahl

Since Specialization

Citations

This map shows the geographic impact of Mirjam Stahl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mirjam Stahl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mirjam Stahl more than expected).

Fields of papers citing papers by Mirjam Stahl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mirjam Stahl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mirjam Stahl. The network helps show where Mirjam Stahl may publish in the future.

Co-authorship network of co-authors of Mirjam Stahl

This figure shows the co-authorship network connecting the top 25 collaborators of Mirjam Stahl. A scholar is included among the top collaborators of Mirjam Stahl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mirjam Stahl. Mirjam Stahl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Syunyaeva, Zulfiya, Simon Y. Graeber, Stephanie Thee, et al.. (2024). Elexacaftor/tezacaftor/ivacaftor improves nasal nitric oxide in patients with cystic fibrosis. Journal of Cystic Fibrosis. 23(5). 863–869. 2 indexed citations

Eichinger, Monika, Angelika Seitz, In go Baumann, et al.. (2024). Magnetic Resonance Imaging of Pulmonary and Paranasal Sinus Abnormalities in Children with Primary Ciliary Dyskinesia Compared to Children with Cystic Fibrosis. Annals of the American Thoracic Society. 21(3). 438–448. 1 indexed citations

Wielpütz, Mark O., Mirjam Stahl, Simon M. F. Triphan, et al.. (2024). Longitudinal Magnetic Resonance Imaging of Changes in Lung Morphology and Perfusion in Children with Cystic Fibrosis from Infancy Through Adolescence. Annals of the American Thoracic Society. 22(1). 93–103.

Stahl, Mirjam, Jobst Roehmel, Monika Eichinger, et al.. (2024). Long-Term Impact of Lumacaftor/Ivacaftor Treatment on Cystic Fibrosis Disease Progression in Children 2–5 Years of Age Homozygous for F508del-CFTR : A Phase 2, Open-Label Clinical Trial. Annals of the American Thoracic Society. 21(11). 1550–1559. 5 indexed citations

Ramsey, Kathryn, Sanja Stanojevic, Noah R. Johnson, et al.. (2024). Global Lung Function Initiative reference values for multiple breath washout indices. European Respiratory Journal. 64(6). 2400524–2400524. 8 indexed citations

Eichinger, Monika, Angelika Seitz, In go Baumann, et al.. (2024). Elexacaftor/tezacaftor/ivacaftor improves chronic rhinosinusitis detected by magnetic resonance imaging in children with cystic fibrosis on long-term therapy with lumacaftor/ivacaftor. Journal of Cystic Fibrosis. 23(2). 234–241. 5 indexed citations

Tiddens, Harm A.W.M., Michaël Fayon, Pierluigi Ciet, et al.. (2023). 146 Standardizing European imaging practice: European Cystic Fibrosis Society—Clinical Trial Network Imaging Special Interest Groups. Journal of Cystic Fibrosis. 22. S77–S77. 1 indexed citations

Vijverberg, Susanne J. H., Asterios Kampouras, Heidi Makrinioti, et al.. (2023). ERS International Congress 2023: highlights from the Paediatrics Assembly. ERJ Open Research. 10(1). 853–2023.

Stahl, Mirjam, Jobst Roehmel, Monika Eichinger, et al.. (2023). Effects of Lumacaftor/Ivacaftor on Cystic Fibrosis Disease Progression in Children 2 through 5 Years of Age Homozygous for F508del-CFTR : A Phase 2 Placebo-controlled Clinical Trial. Annals of the American Thoracic Society. 20(8). 1144–1155. 13 indexed citations

10.

Triphan, Simon M. F., Sabine Wege, Hans‐Ulrich Kauczor, et al.. (2023). Elexacaftor/Tezacaftor/Ivacaftor Improves Bronchial Artery Dilatation Detected by Magnetic Resonance Imaging in Patients with Cystic Fibrosis. Annals of the American Thoracic Society. 20(11). 1595–1604. 3 indexed citations

11.

Wielpütz, Mark O., et al.. (2023). Reanalysis of N2-lung clearance index and the comparison to SF6-lung clearance index and magnetic resonance imaging. Journal of Cystic Fibrosis. 23(1). 150–154. 1 indexed citations

12.

Graeber, Simon Y., Annalisa Addante, Laura Schaupp, et al.. (2023). Effects of Elexacaftor/Tezacaftor/Ivacaftor on Sputum Viscoelastic Properties, Airway Infection and Inflammation in Patients with Cystic Fibrosis. Klinische Pädiatrie. 235(2). 130–131. 1 indexed citations

13.

Sommerburg, Olaf, Monika Eichinger, Sabine Wege, et al.. (2023). Magnetic resonance imaging detects onset and association with lung disease severity of bronchial artery dilatation in cystic fibrosis. ERJ Open Research. 9(2). 473–2022. 7 indexed citations

14.

Eichinger, Monika, Angelika Seitz, In go Baumann, et al.. (2022). Longitudinal Magnetic Resonance Imaging Detects Onset and Progression of Chronic Rhinosinusitis from Infancy to School Age in Cystic Fibrosis. Annals of the American Thoracic Society. 20(5). 687–697. 13 indexed citations

15.

Stahl, Mirjam, Simon Y. Graeber, Cornelia Joachim, et al.. (2021). Magnetic Resonance Imaging Detects Progression of Lung Disease and Impact of Newborn Screening in Preschool Children with Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 204(8). 943–953. 50 indexed citations

16.

Graeber, Simon Y., Sébastien Boutin, Mark O. Wielpütz, et al.. (2021). Effects of Lumacaftor–Ivacaftor on Lung Clearance Index, Magnetic Resonance Imaging, and Airway Microbiome in Phe508del Homozygous Patients with Cystic Fibrosis. Annals of the American Thoracic Society. 18(6). 971–980. 64 indexed citations

17.

Lenz, Dominic, Mirjam Stahl, Elias Seidl, et al.. (2020). Rescue of respiratory failure in pulmonary alveolar proteinosis due to pathogenic MARS1 variants. Pediatric Pulmonology. 55(11). 3057–3066. 19 indexed citations

18.

Sommerburg, Olaf, Mark O. Wielpütz, Mirjam Stahl, et al.. (2020). Magnetic Resonance Imaging Detects Chronic Rhinosinusitis in Infants and Preschool Children with Cystic Fibrosis. Annals of the American Thoracic Society. 17(6). 714–723. 20 indexed citations

19.

Graeber, Simon Y., Mirjam Stahl, Cornelia Joachim, et al.. (2019). P262 Effects of lumacaftor/ivacaftor therapy on lung disease detected by magnetic resonance imaging in F508del homozygous patients with cystic fibrosis. Journal of Cystic Fibrosis. 18. S131–S131. 1 indexed citations

20.

Stahl, Mirjam, Mark O. Wielpütz, Isabell Ricklefs, et al.. (2018). Preventive Inhalation of Hypertonic Saline in Infants with Cystic Fibrosis (PRESIS). A Randomized, Double-Blind, Controlled Study. American Journal of Respiratory and Critical Care Medicine. 199(10). 1238–1248. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact